The study by Sands et all reported promising results with the mathematical technique of power spectrum analysis of heart rate variability to detect graft rejection. We were surprised, however, to learn that they did not find spectral peaks in transplant recipients. In a similar study,2 we detected peaks at the so-called Mayer wave frequency (0.1 Hz) as well as at the frequency of respiratory sinus arrhythmia (RSA). Furthermore, we found that the RSA peak had better repeatability at two weeks (r=0.81) than the Mayer wave frequency and was significantly lower during rejection periods (p=0.039).
Reply Drs. Zbilut and Lawless report finding 0.1-Hz heart rate fluctuations as well as respiratory sinus arrhythmia in heart transplant recipients, which differs from our characterization of heart rate fluctuations in transplant patients as broad-band.' They attribute these differences to our signal processing methodology, claiming that spectral smoothing might cause lowfrequency power to spill over into the respiratory frequency range and obscure the true variability in that range. Furthermore, they report that their measure of variability, peak spectral power of respiratory sinus arrhythmia (PSP-RSA), declined during rejection episodes, whereas our measure of variability (total, 0.02-2.0-Hz power) increased during rejection episodes.
We turn first to the question of whether heart rate fluctuations in transplant patients have discrete peaks or are broad-band. The striking finding in transplant patients compared with normal controls is that variability at all frequencies up to roughly 0.5 Hz is greatly reduced. Indeed, a comparison of Figure 1 (a normal subject) with Figures 3 and 4 (transplant patients with and without rejection) from Zbilut et al2 demonstrates the same finding. Broad-band spectra may appear to have peaks at many frequencies, including the respiratory frequency. However, we found that we could not clearly distinguish a peak at the respiratory frequency from the background noise; this contrasts sharply from the situation with spectra from control subjects in which a distinct peak appears at the respiratory frequency. Zbilut et a13 define the respiratory peak to be the tallest spectral peak found between 0.12 and 0.5 Hz. Their method guarantees the presence of "respiratory sinus arrhythmia" and begs the question of whether respiration has a measurable effect on heart rate variability in transplant recipients. The presence or absence of true respiratory sinus arrhythmia can be ascertained only if a respiratory signal is actually measured and in some way correlated with the heart rate signal. It is interesting to ask whether some small residual respiratory sinus arrhythmia is present in transplant patients and, if so, whether it is due to sinus node stretch, to electrocardiograph axis shift resulting from respiratory movements, or to some other mechanism. If any respiratory sinus arrhythmia exists in transplant recipients, its mechanism surely differs from that in control patients in whom autonomic modulation of the vagal innervation to the heart is implicated. 4 Interestingly, sympathetically and parasympathetically denervated, anesthetized, mechanically ventilated animals have very small residual respiratory frequency variations in heart rates (power reduced 99.8% from control).5
The presence of lower-frequency oscillations is a separate finding of interest. Since publication of our study, we have seen data from a small minority of transplant recipients exhibiting low-frequency oscillations (Phil Saul, personal communication), although the level of variability is still much lower than the low-frequency variability observed in normal subjects.
We agree with Drs. Zbilut and Lawless that in the analysis of data with very low levels of heart rate variability as observed in transplant patients, the presence of signal processing artifacts can significantly affect the results. However, we are confident that our method of spectral smoothing did not leak power into the respiratory frequency range. The width of the smoothing window we used was 0.01 Hz, which is sufficiently narrow to resolve the different spectral peaks (0.02-0.05 Hz, 0.10 Hz, and respiratory frequency fluctuations) observed in normal subjects.
In addition, the spectrum of a linear trend falls off as 1/f4 (f, frequency), so that even a very significant trend relative to the amplitude of heart rate fluctuations would contribute negligibly to the power at respiratory frequencies after spectral smoothing. The respondents in Zbilut et al3 use a nonlinear detrending algorithm that might introduce artifactual peaks. One would expect that their method of quantifying respiratory sinus arrhythmia by measuring a peak height rather than a spectral area would be particularly sensitive to such artifacts.
More significantly, we found that our measure of heart rate variability increased during rejection episodes, whereas Zbilut et al observed a decrease in their measure.3 Even though our measures differ, it is surprising that our observations should indicate opposite trends. The significance levels we and they
